Literature DB >> 19632220

Pilocarpine vs. lithium-pilocarpine for induction of status epilepticus in mice: development of spontaneous seizures, behavioral alterations and neuronal damage.

Christine J Müller1, Marion Bankstahl, Ina Gröticke, Wolfgang Löscher.   

Abstract

In recent years, the pilocarpine model of temporal lobe epilepsy has become the most popular and widely used rodent model of this common and difficult-to-treat type of epilepsy. In this model, the cholinomimetic convulsant pilocarpine is used to induce a status epilepticus, which is followed by hippocampal damage and development of spontaneous recurrent seizures. In rats, pilocarpine is either administered alone or in combination with lithium, which allows a conspicuous reduction of the pilocarpine dose required to induce status epilepticus and results in a higher percentage of animals developing status epilepticus. In mice, lithium has only rarely been used in association with pilocarpine, which prompted us to directly compare the pilocarpine and lithium-pilocarpine models in this species. In contrast to rats, pretreatment with lithium in mice did not potentiate the convulsant effect of pilocarpine. The sequence of behavioral changes observed in mice undergoing a status epilepticus was very similar for lithium-pilocarpine compared to pilocarpine administered alone. All mice that survived status epilepticus developed epilepsy with spontaneous recurrent seizures. Epileptic mice exhibited significant increases of anxiety-related behavior and impaired learning and memory. Neuronal damage resulting from status epilepticus was essentially similar in the lithium-pilocarpine and pilocarpine models and was characterized by severe neurodegeneration in the hippocampal formation, resembling hippocampal sclerosis in mesial temporal lobe epilepsy. Mice in which pilocarpine or lithium-pilocarpine did not induce status epilepticus but only single brief seizures did not show any significant differences in behavior, spatial learning or hippocampal histology from controls. Our data demonstrate that the syndromes produced by pilocarpine and lithium-pilocarpine in mice are behaviorally and neuropathologically indistinguishable, and that both models can be used to study the relationship between seizures, neuronal damage and psychopathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19632220     DOI: 10.1016/j.ejphar.2009.07.020

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  32 in total

Review 1.  Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.

Authors:  Wolfgang Löscher; Claudia Brandt
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Factors affecting outcomes of pilocarpine treatment in a mouse model of temporal lobe epilepsy.

Authors:  Paul S Buckmaster; Megan M Haney
Journal:  Epilepsy Res       Date:  2012-06-19       Impact factor: 3.045

3.  Small molecule anticonvulsant agents with potent in vitro neuroprotection.

Authors:  Douglas E Brenneman; Garry R Smith; Yan Zhang; Yanming Du; Sandeep K Kondaveeti; Michael J Zdilla; Allen B Reitz
Journal:  J Mol Neurosci       Date:  2012-04-26       Impact factor: 3.444

4.  P-gp Protein Expression and Transport Activity in Rodent Seizure Models and Human Epilepsy.

Authors:  Anika M S Hartz; Anton Pekcec; Emma L B Soldner; Yu Zhong; Juli Schlichtiger; Bjoern Bauer
Journal:  Mol Pharm       Date:  2017-03-02       Impact factor: 4.939

Review 5.  Depression, stress, epilepsy and adult neurogenesis.

Authors:  Steve C Danzer
Journal:  Exp Neurol       Date:  2011-06-12       Impact factor: 5.330

Review 6.  Complex metabolically demanding sensory processing in the olfactory system: implications for epilepsy.

Authors:  Diego Restrepo; Jennifer L Hellier; Ernesto Salcedo
Journal:  Epilepsy Behav       Date:  2013-10-07       Impact factor: 2.937

7.  Altered neurotransmitter release, vesicle recycling and presynaptic structure in the pilocarpine model of temporal lobe epilepsy.

Authors:  Chirag Upreti; Rafael Otero; Carlos Partida; Frank Skinner; Ravi Thakker; Luis F Pacheco; Zhen-yu Zhou; Giorgi Maglakelidze; Jana Velíšková; Libor Velíšek; Dwight Romanovicz; Theresa Jones; Patric K Stanton; Emilio R Garrido-Sanabria
Journal:  Brain       Date:  2012-02-16       Impact factor: 13.501

Review 8.  Animal models of temporal lobe epilepsy following systemic chemoconvulsant administration.

Authors:  Maxime Lévesque; Massimo Avoli; Christophe Bernard
Journal:  J Neurosci Methods       Date:  2015-03-10       Impact factor: 2.390

Review 9.  Hippocampal granule cell pathology in epilepsy - a possible structural basis for comorbidities of epilepsy?

Authors:  Michael S Hester; Steve C Danzer
Journal:  Epilepsy Behav       Date:  2014-01-24       Impact factor: 2.937

10.  One hour of pilocarpine-induced status epilepticus is sufficient to develop chronic epilepsy in mice, and is associated with mossy fiber sprouting but not neuronal death.

Authors:  Ling-Lin Chen; Hang-Feng Feng; Xue-Xia Mao; Qing Ye; Ling-Hui Zeng
Journal:  Neurosci Bull       Date:  2013-03-08       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.